Immunotherapy turns the body’s own immune system against cancer. It can be strikingly effective, but it has limits, and a LUMC team wants to push past them by combining two approaches that each engage the immune system in a different…
-
-
When a woman is treated for uterine cancer, the make-up of her tumour shapes the treatment plan, and increasingly that means asking a pathologist to run DNA analysis. One marker matters especially: a mutation in the POLE gene. Patients who…
-
Discharging a patient from intensive care too early raises the chance they’ll be readmitted, which comes with more complications and a higher risk of death. Keeping someone in the ICU longer than necessary carries its own dangers, including hospital-acquired infections.…
-
Leiden, 23 June 2026 What began as a graduation project at Leiden University of Applied Sciences has developed into a successful biotech start-up and a long-term partnership. Leiden University of Applied Sciences and Bionomic B.V. have officially renewed their collaboration…
-
A contribution from Expedition Urban Nature 2026, with thanks to biologist Ben Wielstra of Leiden University and Naturalis On Saturday, 16 May, at 9:00 in the morning, interested participants gathered in the gardens of the Hortus botanicus Leiden for the…
-
In May and June, 2,636 residents of Leiden, Leiderdorp, Oegstgeest and Katwijk jointly spotted 3,939 species of plants, animals and fungi. From seagulls to sea sparkle, from water beetles to plantain, everything was recorded to help map urban nature. Particularly…
-
LEIDEN, Netherlands and CAMBRIDGE, Mass., June 25, 2026 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a clinical-stage biotechnology company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the pricing…
-
LEIDEN, Netherlands & CAMBRIDGE, Mass., June 25, 2026 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR or the Company), a clinical-stage biotechnology company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology…
-
Hermen Overkleeft, professor of bio-organic chemistry at Leiden University, has won the Spinoza Prize for the innovative way in which he is trying to cure cancer and metabolic diseases. The Spinoza Prize is the most important scientific award in the…
-
A study into how the brain and body respond to stressful situations has received the highest scientific grant in the Netherlands. Neuroscientist Karin Roelofs of Radboud University is researching, among other things, the usefulness of the so-called ‘freeze response’. Thanks…
-
A first patient has recently been treated at the LUMC with a new immunotherapy for type 1 diabetes (T1D). This marks an important new phase in the approach to this disease. In type 1 diabetes (T1D), the body’s immune system…
-
LEIDEN, Netherlands–(BUSINESS WIRE)– Dutch biotech Leyden Laboratories B.V. (the “Company” or “Leyden Labs”) today announced a €40 million investment from the European Innovation Council (EIC) Fund, Invest-NL, Gates Foundation, ClavystBio, and others. The financing brings together a strong group of…